Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.27%
#6 Bedrock Bedrock +17.29%
#7 Nillion Nillion +16.73%
#8 Nockchain Nockchain +14.69%
#9 Perle Perle +12.86%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Clasificación en acciones #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Precio por acción
$0.00060315
Última sincronización: 2024-09-27
Capitalización bursátil
$1.65M
Cambio (1 día)
19.64%
Cambio (1 año)
0.00%
País
SE
Comercio Amniotics AB (publ) (AMNI)

Categoría

Healthcare
Ganancias de Amniotics AB (publ) (AMNI)
Ganancias en Dec 2023 TTM: $-3.09M
Secondo gli ultimi rapporti finanziari di Amniotics AB (publ), gli utili attuali della società sono $-3.09M. Nel 2022, la società ha registrato un utile di $-4.61M, un aumento con respecto a agli utili del 2021, che erano di $-5.92M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Amniotics AB (publ) desde 2018 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE